View Profile


Dr Bipin Sethi Kumar
Qualification : MD (Medicine), DM (Endocrinology)  
Designation : Consultant  
Specialty : Endocrinology  
Email : bipinkumarsethi@yahoo.co.uk  
Location : CARE Hospitals, Banjara Hills, Hyderabad
    CARE Outpatient Centre, Banjara Hills, Hyderabad
    CARE Hospitals, Nampally, Hyderabad
Qualifications
  • MBBS — Osmania Medical Medical College, Hyderabad (1982)
  • Internship — Osmania General Hospital and Allied Hospitals, Hyderabad (1983)
  • MD (Medicine) — Postgraduate Institute of Medical Education and Research, Chandigarh (1986)
  • DM (Endocrinology) — Postgraduate Institute of Medical Education and Research, Chandigarh (1988)
Past Positions
  • Civil Asst Surgeon (Rural Service), Mandal Primary Health Centre, Talakondapally (Telangana) (1989-1991)
  • Sr Resident, Postgraduate Institute of Medical Education and Research, Chandigarh (1986-1989)
  • Jr Resident, Postgraduate Institute of Medical Education and Research, Chandigarh (1983-1986)
Teaching experience
  • Asst Professor, Osmania Medical College, Hyderabad (1991-2000)
  • Professor, Kurnool Medical College, Kurnool (2000-2001)
  • Professor, Gandhi Medical College, Hyderabad (2001-2006)
  • Visiting Faculty, National Institute of Nutrition, Hyderabad
Awards & Recognitions
  • Gold medal in Physiology (MBBS)
  • Silver medal for securing top position (MD)
Publications
  • Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, Thomas N, Unnikrishnan A G, Thakkar PB, Malve H. Diabetes insipidus: The other diabetes. Indian J Endocr Metab 2016; 20:9-21
  • Ali MK, Singh K, Kondal D, Devarajan R, Patel SA, Shivashankar R, Sethi Bipin, et al. Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: A randomized, controlled trial. Ann Intern Med, 2016; 165: 6
  • Prasanna Kumar K M, Mohan V, Sethi B, Gandhi P, Bantwal G, Xie J, Meininger G, Qiu R. Efficacy and safety of Canagliflozin in patients with type 2 diabetes mellitus from India. Indian J Endocr Metab 2016; 20: 372-80
  • Sethi B. Trials and tribulations of managing Type 1 DM. Indian J Endocr Metab 2015; 19: 16-7
  • Prasanna Kumar K M, Saboo B, Rao P V, Sarda A, Viswanathan V, Kalra S, Sethi B, Shah N, Srikanta SS, Jain SM, Raghupathy P, Shukla R, Jhingan A, Chowdhury S, Jabbar P K, Kanungo A, Joshi R, Kumar S, Tandon N, Khadilkar V, Chadha M. Type 1 diabetes – awareness, management and challenges: Current scenario in India. Indian J Endocr Metab 2015;19, Suppl S1:6-8
  • Bipin Kumar Sethi, V Sri Nagesh. Weight management in Ramadan. J Pak Med Assoc 2015; 65 (5 Suppl 1):S54-6
  • KelwadeJ, Sethi BK, Vaseem A, Nagesh V S. Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow. Indian J Endocr Metab 2014; 18: 874-5
  • Kelwade J, Sethi BK, Nagesh SV, Vaseem A. A case of "pseudo-ketoacidosis". Indian J Endocr Metab 2014; 18: 743
  • Wangnoo SK, Sethi B, Sahay RK, John M, Ghosal S, Sharma SK. Treat-to-target trials in diabetes. Indian J Endocr Metab 2014; 18: 166-74
  • Sethi B,  Comlekci A,  Gomez-Peralta F,  Landgraf W,  Dain M-P, Pilorget V,  Aschner P. Relationship between glycaemic control and hypoglycaemia using insulin glargine versus premixed insulin in type 2 diabetes: A subanalysis of Galapagos. Diabetologia 2013; 56 Suppl 1: abstract #587
  • S K Wangnoo, D Maji, Bipin Sethi, et al. Barriers and solutions to diabetes management: An Indian perspective. Indian Journal of Endocrinology and Metabolism 2013, 17 (4): 594-601
  • Pablo Aschner, Bipin Sethi, et al. Glargine vs. premixed insulin for management of type 2 diabetes patients failing oral antidiabetic drugs: The Galapagos Study. Diabetes 2013; 62, Suppl 1 A241-242
  • Bipin Kumar Sethi, G V Chanukya, V Sri Nagesh. Prolactin and cancer: Has the orphan finally found a home? Indian Journal of Endocrinology and Metabolism 2012; 16, Suppl 2; 195-198
  • Shashank R. Joshi, Banshi Saboo, Muruga Vadivale, Bipin Kumar Sethi, et al. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India – results from the Screening India’s Twin Epidemic (SITE) Study. Diabetes Technology & Therapeutics 2012; 14: 8-15
  • Bipin K Sethi, Vijay Viswanathan, Ajay Kumar, Sudip Chatterjee, HB Chandalia. Liraglutide in clinical practice: Insights from LEAD programme. Supplement to JAPI, June 2010; (58): 18-22
  • Udwadia F, Bhattacharya A, Seshaiah V, Sethi BK, Kumar S, Subbanna PK, Moharana K, Moses A. Intravenous use of insulin aspart: Observational data from a large population of hospitalised patients. Diabetes 2009; 58 Suppl 1; A 530-531
  • Udwadia F, Bhattacharya A, Seshaiah V, Sethi BK, Kumar S, Subbanna PK, Prusty V, Moses A. Management of in-patient hyperglycemia: Safety of intensive intravenous insulin aspart. Abstract P-1462, 20th World Diabetes Congress, International Diabetes Federation, 2009
  • D Russell-Jones, A Vaag, O Schmitz, B K Sethi, N Lalic, S Antic, M Zdravkovic, G M Ravn, R Simo. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD–5 Metformin + Sulfonylurea): A randomized controlled trial. Diabetologia 2009; 52 (10): 2046-2055
  • Bipin K Sethi, Radha R Chada, Sridhar Chitturi, Shanti K Naidu, Vishnu V Rao, Kavitha Waghray. Prevalence of impaired fasting glucose and type 2 diabetes among south Indian urban school children. Diabetes 2008; 57, Abstract Book Supplement 1 A507
  • BK Sethi, M Chadha, KD Modi, KM Prasanna Kumar, R Mehrotra, Usha Sriram. Efficacy of Teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis – an Indian experience. JAPI 2008; 56: 418-424
Memberships
  • Endocrine Society of India
  • Faculty, Research Society for Study of Diabetes in India (RSSDI)